Jeffrey A. Knauf

13.0k total citations · 3 hit papers
85 papers, 9.6k citations indexed

About

Jeffrey A. Knauf is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Jeffrey A. Knauf has authored 85 papers receiving a total of 9.6k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 52 papers in Endocrinology, Diabetes and Metabolism and 44 papers in Oncology. Recurrent topics in Jeffrey A. Knauf's work include Thyroid Cancer Diagnosis and Treatment (51 papers), Cancer-related Molecular Pathways (41 papers) and S100 Proteins and Annexins (10 papers). Jeffrey A. Knauf is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (51 papers), Cancer-related Molecular Pathways (41 papers) and S100 Proteins and Annexins (10 papers). Jeffrey A. Knauf collaborates with scholars based in United States, Italy and United Kingdom. Jeffrey A. Knauf's co-authors include James A. Fagin, Yuri E. Nikiforov, Marina N. Nikiforova, Zhaowen Zhu, Edna Teruko Kimura, Ronald Ghossein, Julio C. Ricarte‐Filho, Manoj Gandhi, Norisato Mitsutake and Iñigo Landa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Jeffrey A. Knauf

85 papers receiving 9.4k citations

Hit Papers

High prevalence of BRAF m... 2003 2026 2010 2018 2003 2016 2003 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.
    2003 1.2k citations Edna Teruko Kimura, Marina N. Nikiforova et al. profile →
  2. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
    2016 862 citations Iñigo Landa, Tihana Ibrahimpašić et al. Journal of Clinical Investigation profile →
  3. BRAF Mutations in Thyroid Tumors Are Restricted to Papillary Carcinomas and Anaplastic or Poorly Differentiated Carcinomas Arising from Papillary Carcinomas
    2003 823 citations Marina N. Nikiforova, Edna Teruko Kimura et al. The Journal of Clinical Endocrinology & Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey A. Knauf United States 47 6.4k 4.2k 3.7k 1.5k 1.3k 85 9.6k
Italia Bongarzone Italy 45 3.3k 0.5× 3.8k 0.9× 2.9k 0.8× 1.2k 0.8× 1.1k 0.9× 113 7.4k
Massimo Santoro Italy 54 7.6k 1.2× 4.4k 1.0× 4.2k 1.1× 1.8k 1.2× 1.6k 1.3× 114 11.6k
Gennaro Chiappetta Italy 50 2.5k 0.4× 4.3k 1.0× 2.1k 0.6× 834 0.6× 916 0.7× 110 7.4k
Francesca Carlomagno Italy 42 2.5k 0.4× 2.9k 0.7× 2.4k 0.6× 823 0.5× 776 0.6× 92 6.2k
Douglas W. Ball United States 41 2.1k 0.3× 3.4k 0.8× 2.7k 0.7× 741 0.5× 492 0.4× 93 7.1k
Angela Greco Italy 43 1.3k 0.2× 3.2k 0.8× 1.9k 0.5× 789 0.5× 668 0.5× 120 6.3k
Maria Grazia Borrello Italy 41 1.6k 0.3× 2.6k 0.6× 1.6k 0.4× 697 0.5× 532 0.4× 86 4.9k
Mercedes Robledo Spain 44 2.2k 0.4× 2.2k 0.5× 1.2k 0.3× 658 0.4× 506 0.4× 195 6.0k
Hiroyuki Namba Japan 39 2.1k 0.3× 2.2k 0.5× 1.6k 0.4× 699 0.5× 467 0.4× 153 4.7k
Valdemar Máximo Portugal 33 2.0k 0.3× 1.9k 0.5× 1.1k 0.3× 511 0.3× 512 0.4× 83 4.1k

Countries citing papers authored by Jeffrey A. Knauf

Since Specialization
Citations

This map shows the geographic impact of Jeffrey A. Knauf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey A. Knauf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey A. Knauf more than expected).

Fields of papers citing papers by Jeffrey A. Knauf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey A. Knauf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey A. Knauf. The network helps show where Jeffrey A. Knauf may publish in the future.

Co-authorship network of co-authors of Jeffrey A. Knauf

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey A. Knauf. A scholar is included among the top collaborators of Jeffrey A. Knauf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey A. Knauf. Jeffrey A. Knauf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boucai, Laura, Mahesh Saqcena, Fengshen Kuo, et al.. (2023). Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy. Clinical Cancer Research. 29(8). 1620–1630. 23 indexed citations
2.
Lemoine, Pascale, Nicolas Dauguet, Axelle Loriot, et al.. (2022). BRAFV600E Expression in Thyrocytes Causes Recruitment of Immunosuppressive STABILIN-1 Macrophages. Cancers. 14(19). 4687–4687. 2 indexed citations
3.
Saqcena, Mahesh, Luis J. Leandro‐García, Jesper L.V. Mååg, et al.. (2020). SWI/SNF Complex Mutations Promote Thyroid Tumor Progression and Insensitivity to Redifferentiation Therapies. Cancer Discovery. 11(5). 1158–1175. 71 indexed citations
4.
Landa, Iñigo, Nikita Pozdeyev, Christopher Korch, et al.. (2019). Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies. Clinical Cancer Research. 25(10). 3141–3151. 130 indexed citations
5.
Schweppe, Rebecca E., Nikita Pozdeyev, Laura A. Pike, et al.. (2019). Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers. Molecular Cancer Research. 17(5). 1036–1048. 12 indexed citations
6.
Krishnamoorthy, Gnana P., Natalie R. Davidson, Steven D. Leach, et al.. (2018). EIF1AX and RAS Mutations Cooperate to Drive Thyroid Tumorigenesis through ATF4 and c-MYC. Cancer Discovery. 9(2). 264–281. 71 indexed citations
7.
Ibrahimpašić, Tihana, Bin Xu, Iñigo Landa, et al.. (2017). Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of MED12 and RBM10 as Novel Thyroid Cancer Genes Associated with Tumor Virulence. Clinical Cancer Research. 23(19). 5970–5980. 94 indexed citations
8.
Landa, Iñigo, Tihana Ibrahimpašić, Laura Boucai, et al.. (2016). Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. Journal of Clinical Investigation. 126(3). 1052–1066. 862 indexed citations breakdown →
9.
García-Rendueles, María E.R., Julio C. Ricarte‐Filho, Brian R. Untch, et al.. (2015). NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition. Cancer Discovery. 5(11). 1178–1193. 99 indexed citations
10.
Knauf, Jeffrey A., C. F. Gotfredsen, Andrew Pilling, et al.. (2012). GLP-1 Receptor Agonists and the Thyroid: C-Cell Effects in Mice Are Mediated via the GLP-1 Receptor and not Associated with RET Activation. Endocrinology. 153(3). 1538–1547. 112 indexed citations
11.
Couto, Joana, Laura Daly, Ana Paula de Almeida, et al.. (2012). STAT3 negatively regulates thyroid tumorigenesis. Proceedings of the National Academy of Sciences. 109(35). E2361–70. 112 indexed citations
12.
Read, Martin L., Neil Sharma, Robert Seed, et al.. (2011). Proto-oncogene PBF/PTTG1IP Regulates Thyroid Cell Growth and Represses Radioiodide Treatment. Cancer Research. 71(19). 6153–6164. 40 indexed citations
13.
Franco, Aime T., Roberta Malaguarnera, Samuel Refetoff, et al.. (2011). Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice. Proceedings of the National Academy of Sciences. 108(4). 1615–1620. 177 indexed citations
14.
Rivera, Michael, Julio C. Ricarte‐Filho, R. Michael Tuttle, et al.. (2010). Molecular, Morphologic, and Outcome Analysis of Thyroid Carcinomas According to Degree of Extrathyroid Extension. Thyroid. 20(10). 1085–1093. 66 indexed citations
15.
Ricarte‐Filho, Julio C., Mabel Ryder, Dhananjay Chitale, et al.. (2009). Mutational Profile of Advanced Primary and Metastatic Radioactive Iodine-Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles for BRAF, PIK3CA , and AKT1. Cancer Research. 69(11). 4885–4893. 420 indexed citations
16.
Croyle, Michelle, Nagako Akeno, Jeffrey A. Knauf, et al.. (2008). RET/PTC-Induced Cell Growth Is Mediated in Part by Epidermal Growth Factor Receptor (EGFR) Activation: Evidence for Molecular and Functional Interactions between RET and EGFR. Cancer Research. 68(11). 4183–4191. 73 indexed citations
17.
Schweppe, Rebecca E., Joshua Klopper, Christopher Korch, et al.. (2008). Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification. The Journal of Clinical Endocrinology & Metabolism. 93(11). 4331–4341. 490 indexed citations
18.
Mesa, Cléo Otaviano, M. B. Mirza, Norisato Mitsutake, et al.. (2006). Conditional Activation of RET/PTC3 and BRAFV600E in Thyroid Cells Is Associated with Gene Expression Profiles that Predict a Preferential Role of BRAF in Extracellular Matrix Remodeling. Cancer Research. 66(13). 6521–6529. 116 indexed citations
19.
Ouyang, Bin, Jeffrey A. Knauf, Eric P. Smith, et al.. (2006). Inhibitors of Raf Kinase Activity Block Growth of Thyroid Cancer Cells with RET/PTC or BRAF Mutations In vitro and In vivo. Clinical Cancer Research. 12(6). 1785–1793. 113 indexed citations
20.
Nikiforova, Marina N., Edna Teruko Kimura, Manoj Gandhi, et al.. (2003). BRAF Mutations in Thyroid Tumors Are Restricted to Papillary Carcinomas and Anaplastic or Poorly Differentiated Carcinomas Arising from Papillary Carcinomas. The Journal of Clinical Endocrinology & Metabolism. 88(11). 5399–5404. 823 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Italia Bongarzone Breakdown of academic impact, for papers by Massimo Santoro Breakdown of academic impact, for papers by Gennaro Chiappetta Breakdown of academic impact, for papers by Francesca Carlomagno Breakdown of academic impact, for papers by Douglas W. Ball Breakdown of academic impact, for papers by Angela Greco Breakdown of academic impact, for papers by Maria Grazia Borrello Breakdown of academic impact, for papers by Mercedes Robledo Breakdown of academic impact, for papers by Hiroyuki Namba Breakdown of academic impact, for papers by Valdemar Máximo
Rankless by CCL
2026